|
Teachers and Schools Across North America Receive $10,000 Amgen Award for Science Teaching Excellence
|
24 June 2011 |
|
Patrick Dempsey Teams up With Breakaway from Cancer(R)
|
16 May 2011 |
|
Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851
|
23 April 2011 |
|
Amgen's First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
|
21 April 2011 |
|
Amgen Establishes Commercial Operations in Brazil
|
11 April 2011 |
|
Amgen Donates $1 Million to Help Japanese Disaster Victims
|
14 March 2011 |
|
Breakaway From Cancer(R) Launches Newly-Enhanced Website
|
03 March 2011 |
|
Results Published in The Lancet Demonstrate Superiority of XGEVA(TM) (Denosumab)
|
27 February 2011 |
|
Boehringer Ingelheim to Purchase Amgen's Fremont (California) Facility
|
18 January 2011 |
|
Amgen and Xencor Enter Option Deal to Co-Develop Xencor's Novel Antibody for Autoimmune Diseases
|
06 January 2011 |
|
XGEVA(TM) (Denosumab) Significantly Improved Bone Metastasis-Free Survival
|
14 December 2010 |
|
Three Innovative Ideas Receive $10,000 Prizes in Patients | Choices | Empowerment Competition
|
08 December 2010 |
|
Amgen's Nplate(R) Maintains Platelet Counts for More Than Five Years in Adults with Chronic ITP
|
05 December 2010 |
|
Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
|
06 November 2010 |
|
Prolia(TM) (denosumab) Receives Best New Drug Honor at Scrip Awards
|
05 November 2010 |
|
Denosumab Delays the Onset of Bone Complications Compared to Zometa
|
11 October 2010 |
|
Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis(TM)'
|
23 September 2010 |
|
Amgen Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial
|
11 August 2010 |
|
FDA Grants Priority Review Designation to Denosumab
|
19 July 2010 |
|
Amgen Foundation and Changemakers Launch Global Online Competition to Empower Patients
|
15 July 2010 |